• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDIOVASCULAR SYSTEMS, INC. DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM; PERIPHERAL ATHERECTOMY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDIOVASCULAR SYSTEMS, INC. DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM; PERIPHERAL ATHERECTOMY DEVICE Back to Search Results
Model Number DBP-EX-200SOL145
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fistula (1862); Perforation of Vessels (2135); Thrombosis/Thrombus (4440)
Event Date 11/08/2022
Event Type  Injury  
Manufacturer Narrative
Analysis of the reported device is in progress.A supplemental report will be submitted when the device analysis is completed.Csi id: (b)(4).
 
Event Description
A diamondback 360 peripheral orbital atherectomy device (oad) was used to treat a severely calcified left superficial femoral artery (sfa).Intravascular ultrasound (ivus) was inserted into the lesion, however, malfunctioned.While the ivus catheter was being exchanged, the viperwire advance guide wire remained in the sfa for approximately fifteen minutes.Two treatments on low speed and one treatment on high speed were performed.The oad was removed and balloon angioplasty was performed.Angiographic imaging of the lower leg revealed a thrombosis of the tibioperoneal trunk artery (tpt).A non-csi device was used to treat the tpt and popliteal artery.Angiographic imaging was performed and revealed a perforation in the popliteal artery and a fistula in the nearby vein.The area was ballooned to tamponade.Balloon angioplasty and stent placement were performed to complete the procedure.
 
Manufacturer Narrative
The device was returned for analysis.No damage or abnormalities were observed.The crown diameter was within specification.When tested, the device function as intended.The material inspection report for this guidewire lot number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.H6 investigation conclusion code 22: the diamondback 360® peripheral orbital atherectomy system instructions for use manual states that vessel perforation is a potential adverse event that may occur and/or require intervention with use of the system.Csi id: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM
Type of Device
PERIPHERAL ATHERECTOMY DEVICE
Manufacturer (Section D)
CARDIOVASCULAR SYSTEMS, INC.
1225 old hwy 8 nw
st. paul MN 55112
Manufacturer (Section G)
CARDIOVASCULAR SYSTEMS, INC.
1225 old hwy 8 nw
st. paul MN 55112
Manufacturer Contact
tonia moskalets
1225 old hwy 8 nw
st. paul, MN 55112
MDR Report Key15932959
MDR Text Key304991709
Report Number3004742232-2022-00306
Device Sequence Number1
Product Code MCW
UDI-Device Identifier10852528005848
UDI-Public(01)10852528005848(17)230831(10)394250
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K190634
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2023
Device Model NumberDBP-EX-200SOL145
Device Catalogue Number7-10030-04
Device Lot Number394250
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/23/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/08/2022
Initial Date FDA Received12/07/2022
Supplement Dates Manufacturer Received12/15/2022
Supplement Dates FDA Received12/20/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/12/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age51 YR
Patient SexFemale
Patient Weight123 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-